Triazole heterocyclic compound
By developing Cbl-b inhibitor compounds, the problem that Cbl-b has been underutilized in tumor immunotherapy and autoimmune diseases has been solved, and the effect of enhancing T cell activation and reducing tumor growth has been achieved, which has significantly reduced spontaneous tumorigenesis and symptoms of autoimmune disease.
Patent Information
- Application Number
- CN202411061757.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-08-02
AI Technical Summary
As an important immune cell regulator, Cbl-b has not fully utilized its potential role in tumor immunotherapy and autoimmune diseases, and it is difficult for the prior art to effectively develop its inhibitors to improve therapeutic effects.
A Cbl-b inhibitor compound and a pharmaceutical composition thereof are provided, which is prepared by a specific synthetic route for the treatment of diseases such as tumors, type I diabetes, Graves disease, systemic lupus erythematosus and multiple sclerosis.
This compound inhibits Cbl-b, enhances T cell activation, improves the tumor killing ability of CAR-T cells, reduces tumor growth, and effectively treats a variety of autoimmune diseases, significantly reducing the incidence of spontaneous tumors.
Smart Images

Figure CN118978523A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a Cbl-b inhibitor compound, use thereof and a pharmaceutical composition containing the same. Background Art
[0002] Cbl-b (Casitas B-lymphoma) is an E3 ligase containing a Ring finger domain. It is mainly expressed in peripheral immune cells and has the function of regulating the functions of various immune cells.
[0003] In T cells, Cbl-b exists in the cytoplasm and is recruited to the cell membrane after being stimulated by TCR signals, exercising a variety of negative regulatory effects on the TCR signaling pathway, such as degrading CD3ζ, reducing LAT and Vav1 phosphorylation, inhibiting PLC-γ1 activation, etc. At the same time, it can also act downstream of CD28, ubiquitinate the p85β subunit of PI3K, thereby inhibiting the CD28-dependent PI3K pathway, reducing the activation threshold of T cells, and activating them without costimulatory signals. Cbl-b knockout T cells showed a significant increase in proliferation activity, increased expression of cytokines such as IL-2, increased expression of active markers, and decreased expression of exhaustion markers. At the same time, they were more tolerant to negative regulatory signals such as Treg, TGF-β, and PD-L1. Cbl-b knockout CAR-T cells showed a stronger tumor killing effect, and when Cbl-b knockout T cells were combined with immune checkpoint inhibitor CTLA-4 antibodies, tumor growth was better inhibited.
[0004] In B cells, downstream molecules of the BCR signaling pathway, such as Syk, PLC-γ2, p85 / PI3K, Vav, and Grb2, are all Cbl-b substrates, and its knockout keeps B cells in a state of sustained activation, such as increased Ca2+ flow and increased expression of the activation marker CD69. In addition, Cbl-b also plays a regulatory role in innate immune cells, such as macrophages, dendritic cells, NK cells, and monocytes.
[0005] Systematic knockout of Cbl-b in mice has no significant effect on their growth and reproduction, and only presents spontaneous autoimmune disease symptoms, such as increased anti-double-stranded DNA autoantibodies in serum and inflammatory cell infiltration in multiple organs. CBL-B knockout mice are also more sensitive to a variety of autoimmune models. Due to the regulatory effect of Cbl-b on a variety of immune cells, the incidence of spontaneous tumors in Cbl-b knockout mice is significantly reduced. For a variety of transplanted tumor models, including solid tumors and hematological tumors, their growth has also been significantly inhibited.
[0006] In addition, single nucleotide polymorphisms (SNPs) and mutations of Cbl-b are associated with a variety of human autoimmune diseases, such as type 1 diabetes, Graves' disease, systemic lupus erythematosus and multiple sclerosis.
[0007] In summary, Cbl-b is an important regulator of immune cell activity and a potential therapeutic target for tumor immunotherapy and autoimmune diseases. Summary of the invention
[0008] The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof:
[0009]
[0010] Where R1 is independently C 1-3 Alkyl, -CN, halogen or hydroxyl, n is 1 or 2
[0011] Furthermore, when R1 is C 1-3 Alkyl, R1 may be optionally substituted by halogen or -CN.
[0012] The compound represented by formula (I) or a pharmaceutically acceptable salt thereof may be:
[0013]
[0014] The present invention also provides the use of the above-mentioned compound or a pharmaceutically acceptable salt thereof in preparing a Cbl-b inhibitor, such as tumors, type I diabetes, Graves' disease, systemic lupus erythematosus and multiple sclerosis.
[0015] The present invention also provides a pharmaceutical composition, which comprises the compound shown above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
[0016] As used herein, the term "pharmaceutically acceptable salt" refers to a pharmaceutically acceptable organic or inorganic salt of a compound of the present invention. DETAILED DESCRIPTION
[0017] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.
[0018] The structures of the compounds described in the following examples were confirmed by nuclear magnetic resonance (NMR) and / or mass spectrometry (MS).
[0019] The nuclear magnetic resonance (NMR) was measured using a Bruker 400 MHz NMR instrument, the measuring solvents were deuterated methanol (CD3OD), deuterated chloroform (CDCl3), hexadeuterated dimethyl sulfoxide (DMSO-d6), and the internal standard substance was tetramethylsilane (TMS).
[0020] The abbreviations in the nuclear magnetic resonance (NMR) data in the following examples represent the following meanings:
[0021] s: singlet, d: doublet, t: triplet, q: quartet, dd: doublet of doublets, m: multiplet, br: broad, J: coupling constant, Hz: Hertz, δ: chemical shift.
[0022] All chemical shift (δ) values are given in parts per million (ppm).
[0023] The mass spectrometry (MS) was performed using an Agilent 6120B mass spectrometer, and the ion source was an electrospray ionization source (ESI).
[0024] Intermediate Preparation Example
[0025] Synthesis of Int-A:
[0026]
[0027] Step 1:
[0028] Nitric acid (8.91 g, 141.32 mmol, 6.36 mL) was added to a solution of methyl 4-bromo-3-(trifluoromethyl)benzoate (20.0 g, 70.66 mmol) in sulfuric acid (300.0 mL). The resulting mixture was stirred at 80 °C for 2 hours. TLC monitoring showed the generation of a major new spot (PE:EA=5:1, R f =0.1). The mixture was slowly poured into ice water, filtered, and the filter cake was concentrated in vacuo to obtain a crude product Int-A1 (20.0 g, 63.69 mmol, yield 90%) as a white solid, which was directly used in the next reaction.
[0029] Step 2:
[0030] Sulfuric acid (62.5 g, 636.90 mmol, 33.9 mL) was slowly added dropwise to a solution of Int-A1 (20 g, 63.69 mmol) in methanol (250.0 mL). The mixture was stirred at 80 °C for 2 hours. TLC showed that the reactants were completely consumed and a new spot was detected (PE:EA=10:1, R f=0.8). The reaction mixture was poured into 200 mL of ice water, filtered, and the filter cake was concentrated under reduced pressure to obtain a crude product Int-A2 (18.75 g, 57.32 mmol, yield 90%) as a white solid. 1 H NMR (DMSO-d6, 400MHz) δ = 8.77 (s, 1H), 8.39 (s, 1H), 3.94 (s, 3H).
[0031] Step 3:
[0032] Int-A2 (15.0 g, 45.73 mmol) was dissolved in ethanol (200.0 mL), and then iron powder (7.66 g, 137.18 mmol), ammonium chloride (7.34 g, 137.18 mmol) and water (20.0 mL) were added. The reaction solution was stirred at 25 ° C for 3 hours. LCMS showed that the reactants had been consumed. The reaction solution was filtered, then diluted with 200 mL of water and extracted with 300 mL of ethyl acetate (150 mL*2). The combined organic layer was washed with 200 mL of saturated brine (100 mL*2), dried over sodium sulfate, filtered and concentrated under reduced pressure to obtain a crude product Int-A3 (10.0 g, 33.55 mmol, yield 73%) as a gray solid, which was directly used in the next step, LCMS (ESI) m / z = 298.0, 300.0 [M+H] + .
[0033] Step 4:
[0034] Potassium ethylsulfonate (10.76 g, 67.10 mmol) was added to a solution of Int-A3 (10 g, 33.55 mmol) in pyridine (150 mL). The reaction mixture was stirred at 110 °C for 12 hours. LCMS showed that the reactants had been consumed. 200 mL of ice water was added to quench the reaction, then 100 mL of ethyl acetate was added to dilute and extracted with 400 mL (200 mL*2) of ethyl acetate. The combined organic layer was washed with 200 mL (100 mL*2) of saturated brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, petroleum ether / ethyl acetate = 10 / 1 to 1 / 1) to give a brown solid Int-A (4.0 g, 13.64 mmol, yield 41%), LCMS (ESI) m / z = 294.2 [M+H] + .
[0035] Synthesis of Int-B:
[0036]
[0037] Step 1:
[0038] Add iodomethane (14.53 g, 102.29 mmol) to a solution of Int-A (10 g, 34.097 mmol) and potassium carbonate (14.12 g, 102.29 mmol) in ethyl acetate (100 mL). The reaction mixture was stirred at room temperature for 16 hours, then filtered to remove the solid, washed twice with ethyl acetate, and the solvent was dried by spin drying. The yellow solid Int-B1 (2.0 g, yield 19%) was purified by column chromatography. LCMS (ESI) m / z = 307.9 [M+H] + .
[0039] Step 2:
[0040] Add lithium aluminum tetrahydride (0.74 g, 19.52 mmol) to a tetrahydrofuran (20 mL) solution of Int-B1 (3.0 g, 9.76 mmol) at 0°C and react at 0°C for 1 hour. Quench the reaction with ice water, then filter through diatomaceous earth, wash the filter cake with ethyl acetate several times, separate the filtrate, extract the aqueous phase with ethyl acetate, combine the organic phases, dry and spin dry to obtain a yellow solid Int-B2 (2.3 g, yield 84%). LCMS (ESI) m / z = 280.0 [M+H] + .
[0041] Step 3:
[0042] Manganese dioxide (7.16 g, 82.35 mmol) was added to a solution of Int-B2 (2.3 g, 8.23 mmol) in dichloromethane (30 mL). The mixture was reacted at room temperature for 16 hours, and the solvent was dried and purified by column chromatography to obtain a yellow solid Int-B3 (1.5 g, yield 66%). LCMS (ESI) m / z = 278.0 [M+H] + .
[0043] Step 4:
[0044] Triethylamine (1.39 g, 13.74 mmol) was added to a solution of Int-B3 (635 mg, 2.29 mmol) and (S)-3-methylpiperidine hydrochloride (465.94 mg, 3.44 mmol) in dichloroethane (20 mL). The reaction mixture was stirred at room temperature for 1 hour. Sodium triacetoxyborohydride (0.97 g, 4.58 mmol) was then added to the reaction solution, and the reaction mixture was stirred at room temperature for another 3 hours. The solvent was then dried and purified by column chromatography to give a yellow oil Int-B (680 mg, yield 82%), LCMS (ESI) m / z = 361.1 [M+H] + .
[0045] Synthesis of Int-C:
[0046]
[0047] Step 1:
[0048] Int-A (10.0 g, 34.1 mmol) was dissolved in acetic acid (100.0 mL), and then iron powder (19.04 g, 341.0 mmol) was added. The reaction solution was stirred at 110 ° C for 16 hours. Then filtered through diatomaceous earth, and the filtrate was washed with 100 mL of ethyl acetate. It was neutralized with 200 mL of saturated sodium bicarbonate solution and extracted with 200 mL (100 mL * 2) of ethyl acetate. The combined organic layer was washed with 200 mL (100 mL * 2) of saturated brine. Dry over sodium sulfate, filter and concentrate under reduced pressure. The obtained residue was purified by column chromatography (SiO2, petroleum ether / ethyl acetate = 5 / 1 to 3 / 1) to give a light yellow solid Int-C1 (6.5 g, 24.88 mmol, yield 73%), LCMS (ESI) m / z = 262.2 [M + H] + .
[0049] Step 2:
[0050] To a solution of Int-C1 (2.0 g, 7.66 mmol) in tetrahydrofuran (200.0 mL) was added lithium aluminum tetrahydride (581.2 mg, 15.31 mmol) at 0°C. After the reaction solution was reacted at 0°C for 1 hour, water (15 mL), 15% sodium hydroxide solution (15 mL) and water (45 mL) were added at 0°C to quench the reaction. The filtrate was filtered and concentrated under reduced pressure to obtain a residue which was purified by column chromatography (SiO2, petroleum ether / ethyl acetate = 10 / 1 to 3 / 1) to give a yellow solid Int-C2 (1.2 g, 5.15 mmol, yield 67%), LCMS (ESI) m / z = 233.9 [M+H] + Step 3:
[0051] Dissolve Int-C2 (1.19 g, 5.10 mmol) in dichloromethane (20.0 mL) solution, then add thionyl chloride (7.3 g, 61.2 mmol, 4.4 mL) dropwise. The reaction solution was stirred at 25 °C for 1 hour, and LCMS monitoring showed that the reactant had been consumed. The reaction solution was concentrated under reduced pressure and vacuum-dried to obtain a brown solid crude product Int-C (1.2, 4.77 mmol, yield 93%), which was directly used in the next step. LCMS (ESI) m / z = 252.2 [M+H] + .
[0052] Synthesis of Int-D and Int-E:
[0053]
[0054] Step 1:
[0055] To a solution of methyl 2-(3-bromophenyl)acetate (20.0 g, 87.31 mmol) in DMF (300.0 mL) was added NaH (13.9 g, 349.24 mmol, 60% purity) and stirred at 0°C for 1 hour. Then 1,3-dibromo-2-methyl-propane (22.6 g, 104.77 mmol) was added to the reaction solution. After the reaction solution was stirred at 20°C for 2 hours, 400 mL of aqueous ammonium chloride solution was added at 0°C to quench the reaction, then diluted with 200 mL of water and extracted three times with ethyl acetate (300 mL*3). The combined organic phase was washed three times with a saturated aqueous salt solution (300 mL*3) and dried over sodium sulfate. The residue was filtered and concentrated under reduced pressure, and then purified by column chromatography (petroleum ether / ethyl acetate=5 / 1 to 3 / 1) to give a colorless oil Int-D1 (20.5 g, 72.40 mmol, yield 83%), LCMS (ESI) m / z=294.2 [M+H] + . 1 H NMR (400MHz, CDCl3) δppm 7.51(dt,J=4.98,1.79Hz,1H)7.39(tdd,J=7.70,7.70,1.83,1.10Hz,1H)7.27(s,1H) )7.22-7.16(m,1H)3.71-3.60(m,3H)2.91-2.36(m,3H)1.81-1.62(m,2H)1.48(s,3H).
[0056] Step 2:
[0057] Int-D1 (20.0 g, 70.63 mmol) was dissolved in ethanol (100 mL) solution, and hydrazine hydrate (41.6 g, 706.31 mmol, 40.39 mL, 85% purity) was added. After the reaction solution was stirred at 80°C for 16 hours, the reaction was cooled to room temperature, and the pH of the solution was adjusted to 3-4 with hydrochloric acid solution (1 M), and then the solution was concentrated under reduced pressure. The obtained residue was purified by preparative HPLC (alkaline conditions) to obtain a light yellow oil Int-D2 (14.5 g, 51.21 mmol, yield 73%), LCMS (ESI) m / z = 281.1, 283.1 [M+H] + .
[0058] Step 3:
[0059] At room temperature, N,N-dimethylformamide dimethyl acetal (3.0 g, 25.43 mmol, 3.4 mL) was added dropwise to a solution of Int-D2 (6.0 g, 21.19 mmol) in acetonitrile (60.0 mL). The reaction solution was stirred at 100°C for 1 hour, and then acetic acid (1.27 g, 21.19 mmol, 1.2 mL) was added, and a solution of methylamine in ethanol (5.26 g, 50.85 mmol, 30% purity) was added dropwise. The reaction solution was stirred at 100°C for 1 hour. The reaction solution was concentrated by vacuum distillation to obtain a residue, which was purified by preparative HPLC (FA) to obtain a white solid Int-D (3.0 g, 9.80 mmol, yield 46%), LCMS (ESI) m / z = 306.0, 308.0 [M+H] + .
[0060] Step 4:
[0061] Int-D (500.0 mg, 1.63 mmol) was dissolved in a dioxane (20.0 mL) solution, and bis-pinacolato diboron (497.6 mg, 1.96 mmol), 1,1'-bis(diphenylphosphino)ferrocene palladium dichloride (119.48 mg, 0.16 mmol), and potassium acetate (240.4 mg, 2.45 mmol) were added, and the mixture was degassed and filled with nitrogen three times, and then reacted at 100°C under a nitrogen atmosphere for 1 hour. The reaction solution was filtered and concentrated under reduced pressure, and the obtained residue was purified by preparative HPLC (FA conditions) to obtain a brown oil Int-E (500.0 mg, 1.42 mmol, yield 87%), LCMS (ESI) m / z=354.5 [M+H] + .
[0062] Synthesis of Int-F:
[0063]
[0064] Step 1:
[0065] In a 1L round-bottom flask, sodium hydride (7.57g, 315.45mmol) was dissolved in tetrahydrofuran (500mL), and a solution of trimethyl phosphoacetate (31.60g, 173.50mmol) in tetrahydrofuran (50mL) was added dropwise at 0°C. The mixture was reacted for 1 hour under nitrogen protection at 0°C, and then a solution of 3-oxo-cyclobutanecarbonitrile (15g, 157.73mmol) in tetrahydrofuran (50mL) was added. After the reaction solution was stirred at room temperature overnight, it was quenched with aqueous ammonium chloride solution and extracted with ethyl acetate. The organic phase was dried and purified by column chromatography (PE / EA=5:1) to obtain a white solid Int-F1 (6.2g, yield 26%), LCMS (ESI) m / z=152.0[M+H] + .1 H NMR (400MHz, DMSO-d6) δ5.76 (p, J = 2.3Hz, 1H), 3.58–3.45 (m, 2H), 3.40–3.28 (m, 1H), 3.28–3.16 (m, 2H).
[0066] Step 2:
[0067] In a 250 mL round-bottom flask, Int-F1 (6.2 g, 41.015 mmol) was dissolved in 1,4-dioxane (60 mL), and potassium hydroxide (2.99 g, 53.32 mmol) in water (30 mL), (3-((tert-butyloxycarbonyl)amino)phenyl)boric acid (14.58 g, 61.52 mmol) and (1,5-cyclooctadiene)chlororhodium (I) dimer (1.01 g, 2.05 mmol) were added. The mixture was stirred overnight under nitrogen protection at room temperature. The reaction mixture was quenched with ammonium chloride solution and extracted with ethyl acetate. The organic phase was dried and purified by column (PE / EA (5:1)) to obtain an off-white solid Int-F2 (4.9 g, yield 35%), LCMS (ESI) m / z = 345.0 [M+H] + .
[0068] Step 3:
[0069] In a 250 mL round-bottom flask, Int-F2 (4.9 g, 14.23 mmol) was dissolved in tetrahydrofuran (50 mL), and lithium hydroxide (0.75 g, 17.78 mmol), water (25 mL) and methanol (12.5 mL) were added. The mixture was stirred overnight under nitrogen at room temperature. The pH of the reaction mixture was adjusted to 3 with hydrochloric acid solution, and then extracted with ethyl acetate. The organic phase was dried and vacuum-dried to obtain the crude product Int-F3 (4.89 g) as an off-white solid. LCMS (ESI) m / z = 353.0 [M+Na] + .
[0070] Step 4:
[0071] In a 250 mL round-bottom flask, Int-F3 (4.89 g, 14.80 mmol) and 4-methylthiosemicarbazide (2.33 g, 22.20 mmol) were dissolved in DMF (50 mL), and DIEA (5.74 g, 44.40 mmol) and HATU (7.32 g, 19.24 mmol) were added. After reacting for four hours under nitrogen at room temperature, NaOH (1 M) (30 mL) was added and the reaction was continued at 50 ° C overnight. The reaction mixture was quenched with ammonium chloride solution and extracted with ethyl acetate. The organic phase was dried to obtain a yellow oil Int-F4 (5.3 g, yield 90%), LCMS (ESI) m / z = 400.1 [M+H] + .
[0072] Step 5:
[0073] In a 250 mL round-bottom flask, Int-F4 (5.3 g, 13.27 mmol) was dissolved in dichloromethane (50 mL), acetic acid (11.15 g, 185.72 mmol) was added, and hydrogen peroxide (30%) (1.13 g, 33.17 mmol) was added at 0°C. The mixture was reacted under nitrogen at room temperature for two hours. The reaction mixture was quenched with sodium bicarbonate solution, then extracted with dichloromethane, and the organic phase was dried and purified by column (DCM / MeOH (10:1)) to obtain a yellow oil Int-F5 (5.0 g, 100%), LCMS (ESI) m / z = 368.1 [M+H] + .
[0074] Step 6:
[0075] In a 250 mL round-bottom flask, Int-F5 (5 g, 13.61 mmol) was dissolved in dichloromethane (50 mL), trifluoroacetic acid (50 mL) was added, and the mixture was reacted under nitrogen at room temperature for half an hour. The solvent was dried and purified by reverse phase column (column: C18 silica gel column; mobile phase: acetonitrile aqueous solution (0.1% FA), gradient elution from 10% to 50% in 10 minutes; UV monitoring at 254 nm) to obtain yellow solid Int-F6 (2.5 g, yield 69%), LCMS (ESI) m / z = 268.2 [M+H] + .
[0076] Step 7:
[0077] In a 100 mL round-bottom flask, Int-F6 (2.5 g, 9.35 mmol) and copper bromide (4.18 g, 18.70 mmol) were dissolved in acetonitrile (30 mL). Tert-butyl nitrite (1.45 g, 14.03 mmol) was slowly added at 0°C. The mixture was reacted for one hour under nitrogen at 0°C. The reaction solution was quenched with ammonia and extracted with dichloromethane. The organic phase was dried and purified by reverse phase column (column: C18 silica gel column; mobile phase: acetonitrile aqueous solution (0.1% FA), gradient elution from 10% to 50% in 10 minutes; UV monitoring at 254 nm) to obtain yellow solid Int-F (900 mg, yield 29%), LCMS (ESI) m / z=331.0, 333.0 [M+H] + .
[0078] Synthesis of Int-G:
[0079] Referring to the synthesis method of Int-E, it was synthesized from Int-F as the raw material. LCMS (ESI) m / z = 379.2 [M+H] + .
[0080] Synthesis of Int-H and Int-I:
[0081]
[0082] Referring to the synthesis methods of Int-D and Int-E, 1,1-bis(bromomethyl)cyclopropane was used as the corresponding starting material to synthesize brown oily substances Int-H (LCMS (ESI) m / z = 318.2, 320.2 [M+H] + ). and Int-I(LCMS(ESI)m / z=366.1[M+H] + ).
[0083] Synthesis of Int-J and Int-K:
[0084]
[0085] Referring to the synthesis methods of Int-D and Int-E, 3-bis(bromomethyl)butylene oxide was used as the corresponding starting material to synthesize Int-J (LCMS (ESI) m / z = 334.2, 336.2 [M+H] + ) and Int-K (LCMS (ESI) m / z = 379.2 [M+H] + ).
[0086] Synthesis of Int-L:
[0087]
[0088] Step 1:
[0089] At 0 degrees Celsius, slowly add isopropylmagnesium bromide (1M, 202.0mL) to a solution of m-bromophenylacetonitrile (18.0g, 91.82mmol) in THF (300mL), and then slowly add epichlorohydrin (15.3g, 165.27mmol, 13.0mL). The reaction solution was stirred at 25 degrees Celsius for 45 minutes, and then slowly added isopropylmagnesium bromide (1M, 183.6mL) for more than 30 minutes. The reaction solution was slowly heated to 60°C and stirred for 14 hours. TLC showed that the reactants were completely consumed and a new spot was detected (ethyl acetate / petroleum ether = 2:1, R f =0.4). The reaction solution was slowly poured into ice water, adjusted to pH = 4 with 1M HCl, water (400 mL) was added, ethyl acetate (600 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, petroleum ether / ethyl acetate = 3 / 1 to 1 / 1) to obtain a light yellow oil Int-L1 (12.2 g, yield 53%).
[0090] Step 2:
[0091] Compound Int-L1 (12.0 g, 47.60 mmol) was dissolved in ethanol EtOH (120 mL), and then added to an aqueous solution (36 mL) of sodium hydroxide (7.6 g, 190.40 mmol). The reaction solution was slowly heated to 90 degrees Celsius and stirred for 16 hours. LCMS detected that the reaction was complete, and the reaction solution was adjusted to pH = 1-2 with 2M HCl, water (300 mL) was added, and ethyl acetate (500 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent to obtain a brown oily crude product Int-L2 (11.0 g, yield 85%), which was directly used in the next step without further purification. LCMS (ESI) m / z = 267.9 ({ 79 Br}MH) - ,236.9({ 81 Br}MH) - .
[0092] Step 3:
[0093] To a DMF solution (100 mL) of compound Int-L2 (11.0 g, 40.57 mmol), HATU (18.5 g, 48.69 mmol) and N,N-diisopropylethylamine (10.5 g, 81.15 mmol) were added, and finally N-methylhydrazinethiocarboxamide (5.1 g, 48.69 mmol) was added, and the reaction solution was stirred at 20 degrees Celsius for half an hour. LCMS detected that the reaction was complete, water (400 mL) was added to the reaction solution, ethyl acetate (600 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent, and the residue was separated and purified by chromatography on a C18 reverse phase column (mobile phase, acetonitrile / H2O (0.1% ammonia water), eluted from 20% to 70% for 15 minutes; detector, UV 254 nm.) to obtain a light yellow solid Int-L3 (4.0 g, yield 28%). LCMS (ESI) m / z = 355.9 ({ 79 Br}MH) - ,357.9({ 81 Br}MH) - .
[0094] Step 4:
[0095] Compound Int-L3 (3.8 g, 10.61 mmol) was added to an aqueous solution (20 mL) of sodium hydroxide (4.2 g, 106.07 mmol), and the reaction solution was stirred at 25 degrees Celsius for 16 hours. LCMS detected that the reaction was complete, the reaction solution was adjusted to pH = 1-2 with 1M HCl, water (150 mL) was added, ethyl acetate (300 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent, and the residue was separated and purified by C18 reverse phase column chromatography (mobile phase, acetonitrile / H2O (0.1% formic acid), 35% to 65% elution for twelve minutes; detector, UV 254nm.) to obtain a light yellow solid Int-L4 (3.0 g, yield 83%). LCMS (ESI) m / z = 340.0 ({ 79 Br}M+H) + ,342.0({ 81 Br}M+H) + .
[0096] Step 5:
[0097] Acetic acid (10.0 mL) and hydrogen peroxide (6.8 g, 59.96 mmol, 30% purity) were added to a dichloromethane solution (50.0 mL) of compound Int-L4 (3.0 g, 8.81 mmol), and the reaction solution was stirred at 25 degrees Celsius for 1 hour. LCMS detected that the reaction was complete, and the reaction solution was concentrated under reduced pressure to obtain a light yellow oily crude product Int-L5 (2.5 g, yield 81%), which was directly used in the next step without further purification. LCMS (ESI) m / z = 307.9 ({ 79 Br}M+H) + ,309.9({ 81 Br}M+H) + .
[0098] Step 6:
[0099] To a dioxane solution (2 mL) of compound Int-L5 (100.0 mg, 324.49 umol), 1,1-bis(diphenylphosphino)ferrocenepalladium chloride (23.7 mg, 32.45 umol), potassium acetate (79.6 mg, 811.23 umol) and bis(trifluoroacetic acid) borate (90.6 mg, 356.94 umol) were added, replaced with nitrogen three times, and the reaction solution was stirred at 100 degrees Celsius for 1 hour. LCMS detected that the reaction was complete, the reaction solution was filtered, and the filter cake was washed with ethyl acetate. After the filtrate was concentrated under reduced pressure, a dark brown solid crude product Int-L (105.0 mg, yield 91%) was obtained, which was used directly in the next step without further purification. LCMS (ESI) m / z = 356.1 [M + H] + .
[0100] Synthesis route of Int-M
[0101]
[0102] Step 1:
[0103] NaH (9.18 g, 229.54 mmol, 60% purity) was added in batches to a solution of 3-bromobenzeneacetonitrile (15 g, 76.51 mmol) in DMF (200 mL) at zero degrees Celsius. After addition, the mixture was stirred at 0 degrees Celsius for 1 hour, and then 1,3-dibromo-2,2-dimethoxypropane (24.05 g, 91.82 mmol) was added at 0 degrees Celsius. The resulting mixture was stirred at 60 degrees Celsius for 11 hours. TLC showed that the reactants were completely consumed and a new spot was detected (ethyl acetate / petroleum ether = 20:1, R f =0.45). The reaction mixture was added to a saturated ammonium chloride solution (500 mL) at zero degrees Celsius for quenching, and ethyl acetate (500 mL) was added for extraction. The organic phase was washed with saturated brine (300 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by normal phase column chromatography (mobile phase, petroleum ether / ethyl acetate, 20% to 50% elution for ten minutes; detector, UV 254 nm.) to obtain a yellow oil Int-M1 (5 g, yield 22%). 1 H NMR (400MHz, CD3OD) δppm 7.65(t,J=1.77Hz,1H),7.50(m,2H),7.32-7.39(m,1H),3.28(s,3H),3.18(s,3H),3.05-3.11(m,2H),2.71-2.78(m,2H)
[0104] Step 2:
[0105] At room temperature, the compound Int-M1 (5 g, 16.88 mmol), NaOH (1.35 g, 33.77 mmol), EtOH (50 mL) and water (15 mL) were mixed and stirred at 90 degrees Celsius for 15 hours. LCMS detected that the reaction was complete, and the reaction solution was poured into water (200 mL) and extracted with ethyl acetate (200 mL). The aqueous phase was adjusted to pH 5 with 1M dilute hydrochloric acid. Ethyl acetate (200 mL) was added for extraction, and the organic phase was washed with saturated brine (300 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a crude yellow solid Int-M2 (5.2 g, yield 97%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 312.9 ({ 79 Br}MH) - ,314.9({ 81 Br}MH)- .
[0106] Step 3:
[0107] At room temperature, HATU (7.53 g, 19.80 mmol) and DIPEA (4.26 g, 33.00 mmol) were added to a DMF (50 mL) solution of Int-M2 (5.2 g, 16.50 mmol), and then 4-methylthiosemicarbazide (2.08 g, 19.80 mmol) was added. Stir at 20 degrees Celsius for 16 hours. LCMS detected that the reaction was complete, and the reaction solution was added to an aqueous solution (300 mL), and ethyl acetate (300 mL) was added for extraction. The organic phase was washed three times with saturated brine (300 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a crude yellow oil Int-M3 (6.6 g, yield 99%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 370.2 ({ 79 Br}M-MeO) + ,372.2({ 81 Br}M-MeO) + .
[0108] Step 4:
[0109] NaOH (4.9 g, 122.23 mmol) was added to an aqueous solution (100 mL) of Int-M3 (6.6 g, 16.41 mmol) and stirred at 20 degrees Celsius for 16 hours. LCMS detected that the reaction was complete, the reaction solution was added to water (300 mL), ethyl acetate (300 mL) was added for extraction, the organic phase was washed with saturated brine (300 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a crude yellow oil Int-M4 (6.2 g, yield 98%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 384.2 ({ 79 Br}M+H) + ,386.2({ 81 Br}M+H) + .
[0110] Step 5:
[0111] HOAc (12 mL) and H2O2 (19.07 g, 168.19 mmol, 16.16 mL, 30% purity) were added to a solution of Int-M4 (6.2 g, 17.17 mmol) in DCM (60 mL), and the mixture was stirred at 20 degrees Celsius for 1 hour. The reaction was completed by LCMS detection, and the reaction solution was slowly added to a saturated sodium sulfite solution (300 mL) for quenching, and ethyl acetate (300 mL) was added for extraction. The organic phase was washed with saturated brine (300 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. Then, the organic phase was separated and purified by C18 reverse phase column chromatography (mobile phase, acetonitrile / H2O (0.1% FA), 30% to 70% elution for ten minutes; detector, UV 254 nm.) to obtain a colorless oil Int-M5 (3.1 g, yield 51%). LCMS (ESI) m / z = 352.3 ({ 79 Br}M+H) + ,354.3({ 81 Br}M+H) + .
[0112] Step 6:
[0113] At room temperature, hydrochloric acid (4M, 10mL) was added to a solution of Int-M5 (2.8g, 7.95mmol) in MeOH (40mL), and the mixture was stirred at 80 degrees Celsius for 12 hours. After the reaction was completed by LCMS, the reaction solution was added to 1300mL of water, and ethyl acetate (100mL) was added for extraction. The organic phase was washed with saturated brine (100mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. Then, the mixture was separated and purified by C18 reverse phase column chromatography (mobile phase, acetonitrile / H2O (0.1% FA), 30% to 70% elution for ten minutes; detector, UV 254nm.) to obtain a yellow solid Int-M (2.3g, yield 97%). LCMS (ESI) m / z = 306.2 ({ 79 Br}M+H) + ,308.2({ 81 Br}M+H) + .
[0114] Synthesis route of Int-N:
[0115]
[0116] Step 1:
[0117] t-BuOK (109.9 mg, 0.98 mmol) was added to a solution of Int-M (150.0 mg, 0.49 mmol) and diethyl cyanomethylphosphonate (104.2 mg, 0.59 mmol) in THF (10 mL) at 0 °C and stirred at 20 °C for 2 hours. LCMS detected that the reaction was complete, the reaction solution was added to water (50 mL), ethyl acetate (50 mL) was added for extraction, the organic phase was washed with saturated brine (50 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a crude yellow oil Int-N1 (160 mg, yield 99%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 329.2 [M+H] + .
[0118] Step 2:
[0119] To a methanol (10 mL) solution of compound Int-N1 (140 mg, 425.28 umol), NaBH4 (1.8 g, 47.31 mmol) was added in batches at zero degrees Celsius. The mixture was stirred at 20 degrees Celsius for 12 hours. LCMS detected that the reaction was complete, the reaction solution was added to water (50 mL), ethyl acetate (50 mL) was added for extraction, the organic phase was washed with saturated brine (50 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and then separated and purified by C18 reverse phase chromatography column chromatography (mobile phase, acetonitrile / H2O (0.1% FA), 30% to 70% elution for ten minutes; detector, UV 254nm.), to obtain a colorless oil Int-N2 (45 mg, yield 31%). LCMS (ESI) m / z = 331.2 [M+H] + .
[0120] Step 3:
[0121] B2Pin2 (32.20 mg, 126.81 umol), KOAc (20.74 mg, 211.35 umol), Pd(dppf)Cl2 (7.73 mg, 10.57 umol) were added to a 1,4-dioxane solution (3 mL) of the compound Int-N2 (35 mg, 105.7 umol). The reaction solution was ventilated with nitrogen three times and stirred at 100 degrees Celsius under a N2 atmosphere for 1 hour. LCMS detected that the reaction was complete, and the reaction solution was filtered and concentrated under reduced pressure to obtain a brown oily crude product Int-N (39 mg, yield 97%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 379.3 [M+H] + .
[0122] Synthesis route of Int-O
[0123]
[0124] Step 1:
[0125] Triethylamine (328.35 mg, 3.24 mmol) and methanesulfonic anhydride (423.94 mg, 2.43 mmol) were added to a dichloromethane solution (15 mL) of compound Int-N (500.0 mg, 1.62 mmol), and the reaction solution was stirred at 20 degrees Celsius for 2 hours. LCMS detected that the reaction was complete, water (150 mL) was added to the reaction solution, and then ethyl acetate (300 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent, and the residue was separated and purified by chromatography on a C18 reverse phase column (mobile phase, acetonitrile / H2O, 35% to 70% elution for thirteen minutes; detector, UV 254 nm.) to obtain a light yellow solid Int-O1 (500.0 mg, yield 80%). LCMS (ESI + )m / z=385.9({ 79 Br}M+H) + ,387.9({ 81 Br}M+H) + .
[0126] Step 2:
[0127] Potassium cyanide (252.9 mg, 3.88 mmol) and potassium carbonate (357.8 mg, 2.59 mmol) were added to a dimethyl sulfoxide solution (10 mL) of compound Int-O1 (500.0 mg, 1.29 mmol), the atmosphere was replaced with nitrogen three times, and the reaction solution was stirred at 120 degrees Celsius for 16 hours. The reaction was completed by LCMS detection, and the reaction solution was quenched by adding sodium hypochlorite aqueous solution (150 mL), and then water (100 mL) and ethyl acetate (300 mL) were added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent, and the residue was separated and purified by C18 reverse phase chromatography column (mobile phase, acetonitrile / H2O (0.1% formic acid), 40% to 65% elution for 18 minutes; detector, UV 254 nm.) to obtain light yellow solid Int-O21 (15.0 mg, yield 4%) and light yellow solid Int-O22 (25.0 mg, yield 6%). LCMS (ESI + )m / z=317.0({ 79 Br}M+H) + ,319.0({ 81 Br}M+H) + .
[0128] Step 3:
[0129] To a dioxane solution (1 mL) of compound Int-O21 (15.0 mg, 47.29 umol), 1,1-bis(diphenylphosphino)ferrocenepalladium chloride (3.5 mg, 4.73 umol), potassium acetate (13.9 mg, 141.87 umol) and bis(14.4 mg, 56.75 umol) were added, replaced with nitrogen three times, and the reaction solution was stirred at 100 degrees Celsius for 1 hour. LCMS detected that the reaction was complete, the reaction solution was filtered, and the filter cake was washed with ethyl acetate. The filtrate was concentrated under reduced pressure to obtain a dark brown solid crude product Int-O (15.0 mg, yield 87%), which was used directly in the next step without further purification. LCMS (ESI + )m / z=365.1[M+H] + .
[0130] Synthesis of Int-P
[0131]
[0132] Step 1:
[0133] At zero degrees, a solution of compound Int-M (1.0 g, 3.27 mmol) in THF (6 mL) was added dropwise with a THF solution of methylmagnesium bromide (1.6 M, 10.21 mL), and the reaction solution was stirred at 20 degrees Celsius for 16 hours. LCMS detected that the reaction was complete, and the reaction solution was added to a saturated NH4Cl aqueous solution (50 mL) at zero degrees, and ethyl acetate (50 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent, and the residue was separated and purified by chromatography on a C18 reverse phase column (mobile phase, acetonitrile / H2O (0.1% FA), eluted from 17% to 37% for ten minutes; detector, UV 254 nm.) to obtain a white solid Int-P1 (65.0 mg, yield 8%). LCMS (ESI + )m / z=322.0({ 79 Br}M+H) + ,324.0({ 81 Br}M+H) + .
[0134] Step 2:
[0135] Pd(dppf)Cl2(13.6mg, 18.62umol), KOAc(45.7mg, 465.55umol) and B2Pin2(52.0mg, 204.84umol) were added to a solution of compound Int-P1(60.0mg, 186.22umol) in dioxane(1mL), and the reaction solution was stirred at 100 degrees Celsius for 1 hour. LCMS detected that the reaction was complete, and the reaction solution was concentrated under reduced pressure to obtain a black solid Int-P(60.0mg, yield 87%), which was used directly in the next step without further purification. LCMS(ESI)m / z=370.0[M+H] + .
[0136] Int-Q Synthesis Route
[0137]
[0138] Step 1:
[0139] At room temperature, H2SO4 (9.2 g, 91.93 mmol) was added to a solution of compound Int-M2 (4.0 g, 12.69 mmol) in MeOH (50 mL), and the mixture was stirred at 80°C for 16 hours. After the reaction was completed by LCMS, the reaction solution was filtered and concentrated under reduced pressure, and then purified by chromatography on a C18 reverse phase column (mobile phase, acetonitrile / H2O (0.1% FA), 30% to 70% elution for ten minutes; detector, UV 254 nm) to obtain a light yellow solid Int-Q1 (1.65 g, yield 45%). LCMS (ESI) m / z = 283.0 [M+H] + .
[0140] Step 2:
[0141] BAST (1.41 g, 6.36 mmol) was added dropwise to a DCM (20 mL) solution of Int-Q1 (1.5 g, 5.30 mmol) at zero degrees Celsius. After addition, the mixture was stirred at this temperature for 1 hour. The resulting mixture was stirred at 20°C for 16 hours. LCMS detected that the reaction was complete, the reaction solution was filtered, the filter cake was washed with ethyl acetate and water, the filtrate was extracted, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent to obtain a crude yellow oil Int-Q2 (1.6 g, yield 98%). It was used directly in the next step without further purification. 1H NMR (400 MHz, DMSO-d6) δppm 7.50-7.55 (m, 2H), 7.33-7.39 (m, 2H), 3.62 (s, 3H), 3.37-3.47 (m, 2H), 3.15-3.25 (m, 2H)
[0142] Step 3:
[0143] NaOH (419.48 mg, 10.49 mmol) was added to an aqueous solution (15 mL) of Int-Q2 (1.6 g, 5.24 mmol) and stirred at 20 ° C for 12 hours. LCMS detected that the reaction was complete, the reaction solution was filtered, the filter cake was washed with ethyl acetate and water, the filtrate was extracted, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent to obtain a crude yellow oil Int-Q3 (1.43 g, yield 93%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 288.9 [M + H] + .
[0144] Step 4:
[0145] HATU (2.24 g, 5.90 mmol, 1.2 eq) and DIPEA (1.27 g, 9.83 mmol) were added to a DMF (15 mL) solution of Int-Q3 (1.43 g, 4.91 mmol) and 4-methylthiosemicarbazide (619.94 mg, 5.90 mmol) and stirred at 20 ° C for 16 hours. LCMS detected that the reaction was complete, the reaction solution was filtered, the filter cake was washed with ethyl acetate and water, the filtrate was extracted, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent to obtain a crude brown solid Int-Q4 (1.85 g, yield 99%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 376.0 [M + H] + .
[0146] Step 5:
[0147] NaOH (1.9 g, 47.59 mmol) was added to an aqueous solution (20 mL) of Int-Q4 (1.8 g, 4.76 mmol) and stirred at 20 ° C for 16 hours. LCMS detected that the reaction was complete, the reaction solution was washed with ethyl acetate and water, the filter cake was extracted with the filtrate, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent to obtain a crude yellow oil Int-Q5 (1.71 g, yield 100%). It was used directly in the next step without further purification. LCMS (ESI) m / z = 360.2 [M + H] + .
[0148] Step 6:
[0149] To a solution of Int-Q5 (1.7 g, 4.72 mmol) in DCM (20 mL) was added HOAc (4 mL).
[0150] H2O2 (2mL), stirred at 20°C for 1 hour. LCMS detected that the reaction was complete, and a saturated sodium sulfite solution was added to quench the reaction solution. The reaction solution was washed with ethyl acetate and water to wash the filter cake. The filtrate was extracted, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was concentrated to remove the solvent, and then separated and purified by C18 reverse phase column chromatography (mobile phase, acetonitrile / H2O (0.1% FA), 30% to 70% elution for ten minutes; detector, UV 254nm.) to obtain a colorless oil Int-Q (585mg, yield 37%). LCMS (ESI) m / z = 328.2
[0151] [M+H] + .
[0152] Example 1 Synthesis of Compound Cpd 13
[0153]
[0154] Step 1:
[0155] At room temperature, 1-methylcyclobutyl-1-amine (724.8 mg, 5.96 mmol), K2CO3 (5.5 g, 39.74 mmol) and NaI (893.4 mg, 5.96 mmol) were added to a solution of compound Int-C (1 g, 3.98 mmol) in acetonitrile (20 mL), and the reaction solution was stirred at 20 degrees Celsius for 12 hours. LCMS detected that the reaction was complete, the reaction solution was filtered, and the filter cake was washed with ethyl acetate. The filtrate was concentrated under reduced pressure. The residue was separated and purified by column chromatography (SiO2, petroleum ether / ethyl acetate, 80% to 20% elution for twenty minutes) to obtain a yellow oil Cpd 13-1 (754 mg, yield 63%). LCMS (ESI) m / z = 301.3 [M+H] + .
[0156] Step 2:
[0157] At room temperature, CbzOsu (938.6 mg, 3.76 mmol) and K2CO3 (1.04 g, 7.54 mmol) were added to a DMF (20 mL) solution of compound Cpd 13-1 (754 mg, 2.52 mmol), and the reaction solution was stirred at 20 degrees Celsius for 2 hours. LCMS detected that the reaction was complete, water (50 mL) was added to the reaction solution, ethyl acetate (50 mL) was added for extraction, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was separated and purified by column chromatography (SiO2, petroleum ether / ethyl acetate, eluted from 80% to 40% for 20 minutes) to obtain yellow solid Cpd 13-2 (1 g, yield 91%). LCMS (ESI) m / z = 435.3 [M+H] + .
[0158] Step 3:
[0159] CCl4 (20 mL) was added to a DMF (20 mL) solution of compound Cpd 13-2 (1 g, 2.3 mmol) at room temperature, and then the above system was added at 0 degrees Celsius. t BuONa (442.3 mg, 4.60 mmol), the reaction solution was stirred at 20 degrees Celsius for 2 hours. LCMS detected that the reaction was complete, water (200 mL) was added to the reaction solution, ethyl acetate (200 mL) was added for extraction, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the residue was separated and purified by column chromatography (SiO2, petroleum ether / ethyl acetate, 80% to 40% elution for 20 minutes) to obtain a yellow oil Cpd 13-3 (571 mg, yield 52%). LCMS (ESI)
[0160] m / z=469.2[M+H] + .
[0161] Step 4:
[0162] Int-E-P1 (298 mg, 0.84 mmol), K2CO3 (318 mg, 2.30 mmol) and Pd(dppf)Cl2 (56.1 mg, 0.076 mmol) were added to a solution of compound Cpd 13-3 (360 mg, 0.76 mmol) in 1,4-dioxane (9 mL) and water (3 mL). The reaction solution was ventilated with N2 three times and stirred at 100 degrees Celsius for 1 hour under N2 atmosphere. LCMS detected that the reaction was complete, the reaction solution was filtered, and the filter cake was washed with ethyl acetate. After the filtrate was concentrated under reduced pressure, it was purified by chromatography on a C18 reverse phase column (mobile phase, acetonitrile / H2O (0.1% FA), 5% to 80% elution for 20 minutes; detector, UV 254 nm.) to obtain a yellow oil Cpd 13-4 (243 mg, yield 47%). LCMS (ESI) m / z = 660.4 [M+H] + .
[0163] Step 5:
[0164] Pd / C (200 mg) was added to a MeOH solution (5 mL) of compound Cpd 13-4 (243 mg, 0.37 mmol), and the reaction solution was stirred at 20 degrees Celsius for 16 hours under H2 atmosphere. LCMS detected that the reaction was complete, the reaction solution was filtered, and the filter cake was washed with ethyl acetate. The filtrate was concentrated under reduced pressure and then purified by chromatography on a C18 reverse phase column (mobile phase, acetonitrile / H2O (0.05% ammonia water), 30% to 90% elution for 15 minutes; detector, UV 254 nm.) to obtain a white solid Cpd 13 (138.6 mg, yield 70%) LCMS (ESI) m / z = 526.4 [M+H] + . 1 H NMR (400MHz, CD3OD) δppm 8.33(s,1H),8.29(s,1H),8.19(s,1H),8.05(br d,J=6.72Hz,1H),7.88(s,1H),7.57-7.65(m,2H),3.93(s,2H),3.32(br s,3H),2.94-3.08(m,2H),2.57-2.81(m,3H),2.07-2.26(m,2H),1.74-1.98(m,4H),1.42(s,3H),1.18(d,J=5.99Hz,3H).
[0165] The compounds corresponding to the following Examples 2-8 were obtained by a synthetic method similar to that of Example 1, with the corresponding raw materials replaced.
[0166]
[0167]
[0168]
[0169] Effect Example Biological Experiment Method
[0170] The compounds to be tested were dissolved in 100% DMSO, with a stock concentration of 10 mM. The starting concentration of the test was 10 μM, with three-fold serial dilutions, ten data points, and two replicates for each point.
[0171]
[0172] The binding constant of the compound to Cbl-b was determined by the competition between the detection compound and the fluorescent probe (BODIPY labeled). The experiment used the TR-FRET platform and the reaction was carried out in a 384-well plate. Each well contained 0.5nM biotin-labeled Cbl-b or 2.5nM Cbl, 50nM fluorescent probe, 1X Streptavidin-Tb (Cisbio) and 0.5% DMSO. The reaction buffer was 20mM Hepes, pH 7.5, 150mM NaCl, 0.01% TritionX-100, 0.01% BSA and 0.5M TCEP. The compound was incubated with Cbl-b or Cbl at 25°C for 10min, and the probe and Streptavidin-Tb were added. After incubation at 25°C for 1 hour, the TR-FRET signal was read at 490 / 520nm. Based on the reading, the inhibition percentage of the compound on the probe binding was calculated, and the IC of the compound was calculated using four-parameter fitting. 50 , see Table 1 for details:
[0173] Table 1
[0174]
[0175]
[0176] Where A represents IC 50 ≤100nM; B means 100nM<IC 50 ≤1000nM; C means 1000nM<IC 50 ≤3000nM, “-” means not tested yet.
Claims
1. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof: in, R1 is independently C 1-3 Alkyl, -CN, halogen or hydroxy, n is 1 or 2; When R1 is C 1-3 Alkyl, R1 may be optionally substituted by halogen or -CN.
2. The compound as claimed in claim 1 or a pharmaceutically acceptable salt thereof, which is:
3. A pharmaceutical composition comprising the compound as claimed in claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
4. Use of the compound according to any one of claims 1 to 3 or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition thereof, in the preparation of a Cbl-b inhibitor.
5. The use as claimed in claim 4, comprising tumors, type I diabetes, Graves' disease, systemic lupus erythematosus and multiple sclerosis.
Citation Information
Patent Citations
CBL-B modulators and uses thereof
CN117858865A
CBL-b inhibitors and methods of uses thereof
WO2024017201A1
Heterocyclic compounds, preparation method therefor and use thereof
WO2024153240A1
